IXA is a network, servicedesk and liaison, all in one.
We offer researchers the expertise of grant advisers, business developers and legal experts to help determine a valorisation/ impact strategy. We assist in setting up collaborations with third parties and/or starting new ventures, while managing intellectual property and other legal and financial support. For researchers to develop their skills on valorisation and entrepreneurship, IXA organises workshops, courses and masterclasses on a regular basis. Go to For researchers for more information or have a look at our Workshops & Events page.
For companies, non-profits, governments, health care and educational institutions, etc., we provide a gateway to research expertise, high-tech facilities and research infrastructure, contract research, collaboration and investment opportunities. Go to For companies/non-profits to find out more.
Next to offering a wide range of services, we closely cooperate with other parties within the Amsterdam innovation landscape. When opportunities arise, IXA takes the lead in developing programs and activities to further stimulate economic activity and entrepreneurship in research and education.
The project ChloroSpec, initiated by Alfred Holzwarth and Roberta Croce, establishes as BV. Lead by Peter Kievit (serial entrepreneur), ChloroSpec is a developer of plant health and stress analysis systems. ChloroSpec has developed a new technology that should become the gold standard in chlorophyll fluorescence monitoring of plants and algae, and analyzes how plants respond […]News
Dr. Ronald van Steden enters into a partnership with the Dutch police. Together they are committed to guide and monitor the new position of ‘director care and safety’ (regisseur zorg en veiligheid) in Amsterdam. Dr. Ronald van Steden, Associate Professor of Public Administration at the Vrije Universiteit Amsterdam and Senior Researcher at the NSCR, has […]News
A small fragment of a llama antibody, also called ‘nanobody’, is capable of reducing human cytomegalovirus (HCMV) in patients, scientists at the Vrije Universiteit and University of Cambridge found in a study. This could lower CMV-associated diseases and mortality during life-saving solid organ and stem cell transplantation and could be a potential lifesaving drug. HCMV […]News